Global Lung Cancer Diagnostics Market Size, Share Report, Analysis, Trends, Growth 2032
Lung Cancer Diagnostics Market: by Type (Non-small Cell Lung Cancer and Small Cell Lung Cancer) and Test (Biopsy, Imaging Test, Molecular Test, Sputum Cytology, and Others), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | Growth Rate (in %) | Base Year |
|---|---|---|---|
| USD 13987.64 Million | USD 26,261.54 Million | CAGR at 7.25% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Lung Cancer Diagnostics Market, 2016-2025 (USD Million)
- 2.2. Lung Cancer Diagnostics Market, 2016-2025 (USD Million)
- 2.3. Lung Cancer Diagnostics Market: Snapshot
- Chapter 3. Lung Cancer Diagnostics Market - Industry Analysis
- 3.1. Lung Cancer Diagnostics Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Driver 1
- 3.2.2. Driver 2
- 3.3. Restraints
- 3.3.1. Restraint 1
- 3.3.2. Restraint 2
- 3.4. Opportunity
- 3.4.1. Government funding and support
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis By Type
- 3.6.2. Market attractiveness analysis By Test
- 3.6.3. Market attractiveness analysis by Region
- Chapter 4. Lung Cancer Diagnostics Market- Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Lung Cancer Diagnostics Market: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Type launches
- 4.2.3. Agreements, partnerships, collaborations and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Lung Cancer Diagnostics Market -Type Analysis
- 5.1. Global Lung Cancer Diagnostics Market overview: By Type type
- 5.1.1. Global Lung Cancer Diagnostics Market share, By Type,2018 and 2025
- 5.2. Non-small Cell Lung Cancer
- 5.2.1. Global Lung Cancer Diagnostics Market by Non-small Cell Lung Cancer, 2016-2025 (USD Million)
- 5.3. Small Cell Lung Cancer
- 5.3.1. Global Lung Cancer Diagnostics Market by Small Cell Lung Cancer, 2016-2025 (USD Million)
- 5.1. Global Lung Cancer Diagnostics Market overview: By Type type
- Chapter 6. Global Lung Cancer Diagnostics Market -Test Analysis
- 6.1. Global Lung Cancer Diagnostics Market overview: By Test
- 6.1.1. Global Lung Cancer Diagnostics Market share, By Test, 2018 and 2025
- 6.2. Biopsy
- 6.2.1. Global Lung Cancer Diagnostics Market By Biopsy, 2016-2025 (USD Million)
- 6.3. Imaging Test
- 6.3.1. Global Lung Cancer Diagnostics Market By Imaging Test, 2016-2025 (USD Million)
- 6.4. Molecular Test
- 6.4.1. Global Lung Cancer Diagnostics Market By Molecular Test, 2016-2025 (USD Million)
- 6.5. Sputum Cytology
- 6.5.1. Global Lung Cancer Diagnostics Market By Sputum Cytology, 2016-2025 (USD Million)
- 6.6. Others
- 6.6.1. Global Lung Cancer Diagnostics Market by Other Tests, 2016-2025 (USD Million)
- 6.1. Global Lung Cancer Diagnostics Market overview: By Test
- Chapter 7. Global Lung Cancer Diagnostics Market - Regional Analysis
- 7.1. Global Lung Cancer Diagnostics Market overview: by Region
- 7.1.1. Global Lung Cancer Diagnostics Marketshare, by Region, 2018 and 2025
- 7.2. North America
- 7.2.1. North America Lung Cancer Diagnostics Market, 2016-2025 (USD Million)
- 7.2.2. North America Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.2.3. North America Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.2.4. The U.S.
- 7.2.4.1. The U.S.Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.2.4.2. The U.S.Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.2.5. Rest of North America
- 7.2.5.1. Rest of North America Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.2.5.2. Rest of North America Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Lung Cancer Diagnostics Market, 2016-2025 (USD Million)
- 7.3.2. Europe Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.3.3. Europe Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.3.4. UK
- 7.3.4.1. U.K.Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.3.4.2. U.K.Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.3.5. France
- 7.3.5.1. France Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.3.5.2. France Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.3.6. Germany
- 7.3.6.1. Germany Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.3.6.2. Germany Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.3.7. Rest of Europe
- 7.3.7.1. Rest of EuropeLung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.3.7.2. Rest of EuropeLung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Lung Cancer Diagnostics Market, 2016-2025 (USD Million)
- 7.4.2. Asia Pacific Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.4.3. Asia Pacific Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.4.4. China
- 7.4.4.1. China Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.4.4.2. China Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.4.5. Japan
- 7.4.5.1. Japan Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.4.5.2. Japan Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.4.6. India
- 7.4.6.1. India Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.4.6.2. India Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.4.7. Rest of Asia Pacific
- 7.4.7.1. Rest of Asia Pacific Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.4.7.2. Rest of Asia Pacific Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Lung Cancer Diagnostics Market, 2016-2025 (USD Million)
- 7.5.2. Latin America Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.5.3. Latin America Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.5.4. Brazil
- 7.5.4.1. Brazil Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.5.4.2. Brazil Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.5.5. Rest of LatinAmerica
- 7.5.5.1. Rest of LatinAmerica Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.5.5.2. Rest of LatinAmerica Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.6. The Middle East and Africa
- 7.6.1. The Middle East and Africa Lung Cancer Diagnostics Market, 2016-2025 (USD Million)
- 7.6.2. The Middle East and Africa Lung Cancer Diagnostics Market revenue, By Type,2016-2025 (USD Million)
- 7.6.3. The Middle East and Africa Lung Cancer Diagnostics Market revenue, By Test, 2016-2025 (USD Million)
- 7.1. Global Lung Cancer Diagnostics Market overview: by Region
- Chapter 8. Company Profiles
- 8.1. Roche Diagnostics
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Type Portfolio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. bioMérieux
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Type Portfolio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. Thermo Fisher Scientific
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Type Portfolio
- 8.3.4. Business Strategy
- 8.3.5. Recent Developments
- 8.4. Illumina Inc.
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Type Portfolio
- 8.4.4. Business Strategy
- 8.4.5. Recent Developments
- 8.5. Qiagen N.V.
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Type Portfolio
- 8.5.4. Business Strategy
- 8.5.5. Recent Development
- 8.6. Agilent Technologies
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Type Portfolio
- 8.6.4. Business Strategy
- 8.6.5. Recent Development
- 8.7. Sanofi S.A.
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Type Portfolio
- 8.7.4. Business Strategy
- 8.7.5. Recent Development
- 8.8. AstraZeneca plc
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Type Portfolio
- 8.8.4. Business Strategy
- 8.8.5. Recent Development
- 8.9. Janssen
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Type Portfolio
- 8.9.4. Business Strategy
- 8.9.5. Recent Development
- 8.1. Roche Diagnostics
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Lung Cancer Diagnostics Market, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Lung Cancer Diagnostics Market attractiveness, By Type
6. Global Lung Cancer Diagnostics Market attractiveness, By Test
7. Global Lung Cancer Diagnostics Market share, By Type, 2018 and 2025
8. Global Lung Cancer Diagnostics Market by Non-small Cell Lung Cancer, 2016–2025 (USD Billion)
9. Global Lung Cancer Diagnostics Market by Small Cell Lung Cancer,2016–2025 (USD Billion)
10. Global Lung Cancer Diagnostics Market share, By Test, 2018 and 2025
11. Global Lung Cancer Diagnostics Market By Biopsy , 2016–2025 (USD Billion)
12. Global Lung Cancer Diagnostics Market By Imaging Test, 2016–2025 (USD Billion)
13. Global Lung Cancer Diagnostics Market By Molecular Test, 2016–2025 (USD Billion)
14. Global Lung Cancer Diagnostics Market By Sputum Cytology, 2016–2025 (USD Billion)
15. Global Lung Cancer Diagnostics Market By Others, 2016–2025 (USD Billion)
16. Global Lung Cancer Diagnostics Market share, by Region, 2018and 2025
17. North America Lung Cancer Diagnostics Market, 2016–2025 (USD Billion)
18. Europe Lung Cancer Diagnostics Market, 2016–2025 (USD Billion)
19. Asia Pacific Lung Cancer Diagnostics Market, 2016–2025 (USD Billion)
20. Latin America Lung Cancer Diagnostics Market, 2016–2025 (USD Billion)
21. The Middle East and Africa Lung Cancer Diagnostics Market, 2016–2025 (USD Billion)
Table Of Tables
List of Tables
1. Global Lung Cancer Diagnostics Market: snapshot
2. Drivers of the Lung Cancer Diagnostics Market: impact analysis
3. Restraints of the Lung Cancer Diagnostics Market: impact analysis
4. North America Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
5. North America Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
6. The U.S. Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
7. The U.S. Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
8. Rest of North America Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
9. Rest of North America Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
10. Europe Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
11. Europe Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
12. U.K. Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
13. U.K. Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
14. France Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
15. France Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
16. Germany Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
17. Germany Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
18. Rest of Europe Lung Cancer Diagnostics revenue, By Type,2016–2025 (USD Billion)
19. Rest of Europe Lung Cancer Diagnostics revenue, By Test, 2016–2025 (USD Billion)
20. Asia Pacific Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
21. Asia Pacific Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
22. China Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
23. China Lung Cancer Diagnostics revenue, By Test, 2016–2025 (USD Billion)
24. Japan Lung Cancer Diagnostics revenue, By Type,2016–2025 (USD Billion)
25. Japan Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
26. India Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
27. India Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
28. Rest of Asia Pacific Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
29. Rest of Asia Pacific Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
30. Latin America Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
31. Latin America Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
32. Brazil Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
33. Brazil Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
34. Rest of Latin America Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
35. Rest of Latin America Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
36. The Middle East and Africa Lung Cancer Diagnostics Market revenue, By Type,2016–2025 (USD Billion)
37. The Middle East and Africa Lung Cancer Diagnostics Market revenue, By Test, 2016–2025 (USD Billion)
Methodology
FrequentlyAsked Questions
Lung cancer diagnostics include tests used to detect lung cancer. They involve imaging, biopsies, and molecular testing.
The global lung cancer diagnostics market is expected to be driven by the increasing lung cancer incidence, early detection initiatives, and advances in molecular and imaging diagnostics.
According to study, the global lung cancer diagnostics market size was worth around USD 13.99 Billion in 2023 and is predicted to grow to around USD 26.26 Billion By 2032.
The global lung cancer diagnostics market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 7.25% during the forecast period from 2024-2032.
The global lung cancer diagnostics industry is projected to be challenged by Major challenges include early detection accuracy, high testing costs, and regulatory validation. Limited access and reimbursement uncertainty slow adoption.
The Opportunities include early detection technologies, liquid biopsy adoption, and AI-driven imaging. Screening programs and precision oncology support growth will offer significant growth opportunities in the lung cancer diagnostics market.
Liquid biopsy and molecular diagnostics; AI-driven imaging analysis; focus on early-stage detection are the emerging trends and innovations impacting the lung cancer diagnostics market.
The global lung cancer diagnostics market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global lung cancer diagnostics market are; Roche Diagnostics, bioMérieux, Thermo Fisher Scientific, Illumina Inc., Qiagen N.V., Agilent Technologies, Sanofi S.A., AstraZeneca plc, and Janssen among others. and others.
The report explores crucial aspects of the lung cancer diagnostics market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
